Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN

Stem Cells Translational Medicine

Volumn 2, Issue 4, 2013, Pages 265-273

  Tateno, Hiroaki ^a   Matsushima, Asako ^a   Hiemori, Keiko ^a   Onuma, Yasuko ^a   Ito, Yuzuru ^a   Hasehira, Kayo ^a   Nishimura, Ken ^a   Ohtaka, Manami ^a   Takayasu, Satoko ^a   Nakanishi, Mahito ^a   Ikehara, Yuzuru ^b   Nakanishi, Mio ^c   Ohnuma, Kiyoshi ^c   Chan, Techuan ^c   Toyoda, Masashi ^d,e   Akutsu, Hidenori ^e   Umezawa, Akihiro ^e   Asashima, Makoto ^a,c   Hirabayashi, Jun ^a  

^a Research Center for Stem Cell Engineering   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^e NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Differentiation antigens and bull; Embryonic stem cells and bull; Glycosaminoglycan and bull; Induced pluripotent stem cells and bull; Microarray and bull; Reprogramming

Indexed keywords

GLYCAN DERIVATIVE; KERATAN SULFATE; LECTIN; PODOCALYXIN; RBC2LCN; SIALIDASE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN MICROARRAY; WESTERN BLOTTING;

EID: 84876239760     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0154     Document Type: Article

References (46)

1. Muramatsu T, Muramatsu H. Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconj J 2004;21:41-45.
2. Andrews PW. Toward safer regenerative medicine. Nat Biotechnol 2011;29:803-805.
3. Lanctot PM, Gage FH, Varki AP. The glycans of stem cells. Curr Opin Chem Biol 2007; 11:373-380.
4. Schopperle WM, DeWolf WC. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. STEM CELLS 2007;25:723-730.
5. Natunen S, Satomaa T, Pitkanen V et al. The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency associated type 1 lactosamine epitope. Glycobiology 2011;21:1125-1130.
6. Tang C, Lee AS, Volkmer JP et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 2011;29:829-834.
7. Tateno H, Toyota M, Saito S et al. Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J Biol Chem 2011; 286:20345-20353.
8. Sulák O, Cioci G, Delia M et al. A TNF-like trimeric lectin domain from Burkholderia cenocepacia with specificity for fucosylated human histo-blood group antigens. Structure 2010;18:59-72.
9. Onuma Y, Tateno H, Hirabayashi J et al. rBC2LCN, a new probe for live cell imaging of human pluripotent stem cells. Biochem Biophys Res Commun 2013;431:524-529.
10. Kuno A, Kato Y, Matsuda A et al. Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification. Mol Cell Proteomics 2009;8:99-108.
11. Nishino K, Toyoda M, Yamazaki-Inoue M et al. Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts. PLoS One 2010;5:e13017.
12. Nagata S, Toyoda M, Yamaguchi S et al. Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. Genes Cells 2009;14:1395-1404.
13. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
14. Makino H, Toyoda M, Matsumoto K et al. Mesenchymal to embryonic incomplete transition of human cells by chimeric OCT4/3 (POU5F1) with physiological co-activator EWS. Exp Cell Res 2009;315:2727-2740.
15. Toyoda M, Yamazaki-Inoue M, Itakura Y et al. Lectin microarray analysis of pluripotent and multipotent stem cells. Genes Cells 2011; 16:1-11.
16. Saito S, Onuma Y, Ito Y et al. Possible linkages between the inner and outer cellular states of human induced pluripotent stem cells. BMC Syst Biol 2011;5(suppl 1):S17.
17. Nishimura K, Sano M, Ohtaka M et al. Development of defective and persistent Sendai virus vector: A unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 2011;286:4760-4771.
18. Suemori H, Yasuchika K, Hasegawa K et al. Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun 2006; 345:926-932.
19. Osafune K, Caron L, Borowiak M et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 2008;26:313-315.
20. Tateno H, Kuno A, Itakura Y et al. A versatile technology for cellular glycomics using lectin microarray. Methods Enzymol 2010;478: 181-195.
21. Duk M, Ugorski M, Lisowska E. Beta-Elimination of O-glycans from glycoproteins transferred to immobilon P membranes: Method and some applications Anal Biochem 1997 253:98-102.
22. Kato Y, Hayatsu N, Kaneko MK et al. Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors. Biochem Biophys Res Commun 2008; 369:1041-1046.
23. Kuno A, Uchiyama N, Koseki-Kuno S et al. Evanescent-field fluorescence-assisted lectin microarray: A new strategy for glycan profiling. Nat Methods 2005;2:851-856.
24. Uchiyama N, Kuno A, Tateno H et al. Optimization of evanescent-field fluorescence-assisted lectin microarray for high-sensitivity detection of monovalent oligosaccharides and glycoproteins. Proteomics 2008;8:3042-3050.
25. Itakura Y, Nakamura-Tsuruta S, Kominami J et al. Systematic comparison of oligosaccharide specificity of Ricinus communis agglutinin I and Erythrina lectins: A search by frontal affinity chromatography. J Biochem 2007;142:459-469.
26. Tateno H, Nakamura-Tsuruta S, Hirabayashi J. Frontal affinity chromatography: Sugar-protein interactions. Nat Protoc 2007;2: 2529-2537.
27. Nakamura S, Yagi F, Totani K et al. Comparative analysis of carbohydrate-binding properties of two tandem repeat-type Jacalinrelated lectins, Castanea crenata agglutinin and Cycas revoluta leaf lectin. FEBS J 2005;272: 2784-2799.
28. Kershaw DB, Beck SG, Wharram BL et al. Molecular cloning and characterization of human podocalyxin-like protein: Orthologous relationship to rabbit PCLP1 and rat podocalyxin. J Biol Chem 1997;272:15708-15714.
29. Schopperle WM, Armant DR, DeWolf WC. Purification of a tumor-specific PNA-binding glycoprotein, gp200, from a human embryonal carcinoma cell line. Arch Biochem Biophys 1992;298:538-543.
30. Takeda T, Go WY, Orlando RA et al. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biol Cell 2000;11:3219-3232.
31. Kerjaschki D, Vernillo AT, Farquhar MG. Reduced sialylation of podocalyxin-the major sialoprotein of the rat kidney glomerulus-in aminonucleoside nephrosis. Am J Pathol 1985; 118:343-349.
32. Dekan G, Gabel C, Farquhar MG. Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glo merular filtration slits. Proc Natl Acad Sci USA 1991;88:5398-5402.
33. Kerjaschki D, Sharkey DJ, Farquhar MGIdentification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 1984;981591-1596.
34. Yamagishi K, Suzuki K, Imai K et al. Purification, characterization, and molecular cloning of a novel keratan sulfate hydrolase, endobeta-N-acetylglucosaminidase, from Bacillus circulans. J Biol Chem 2003;278:25766-25772
35. Yabe R, Itakura Y, Nakamura-Tsuruta S et al. Engineering a versatile tandem repeat-type alpha2-6sialic acid-binding lectin. Biochem Biophys Res Commun 2009;384:204-209.
36. Seko A, Ohkura T, Ideo H et al. NoveO-linked glycans containing 6'-sulfo-Gal/Gal-NAc of MUC1 secreted from human breast cancer YMB-S cells: Possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibodyGlycobiology 2012;22:181-195.
37. Kochibe N, Matta KL. Purification and properties of an N-acetylglucosamine-specific lectin from Psathyrella velutina mushroom J Biol Chem 1989;264:173-177.
38. Hasehira K, Tateno H, Onuma Y et alStructural and quantitative evidence for dynamic glycome shift upon production of human induced pluripotent stem cells. Mol CelProteomics 2012;11:1913-1923.
39. Richards M, Tan SP, Tan JH et al. The transcriptome profile of human embryonic stem cells as defined by SAGE. STEM CELLS 200422:51-64.
40. Bhattacharya B, Miura T, Brandenberger R et al. Gene expression in human embryonic stem cell lines: Unique molecular signatureBlood 2004;103:2956-2964.
41. Zeng X, Miura T, Luo Y et al. Properties of pluripotent human embryonic stem cells BG01 and BG02. STEM CELLS 2004;22:292-312.
42. Hayman MW, Przyborski SA. Proteomic identification of biomarkers expressed by human pluripotent stem cells. Biochem Biophys Res Commun 2004;316:918-923.
43. Dam TK, Gerken TA, Brewer CF. Thermodynamics of multivalent carbohydrate-lectin cross-linking interactions: Importance of entropy in the bind and jump mechanism. Biochemistry 2009;48:3822-3827.
44. Nielsen JS, McNagny KM. The role of podocalyxin in health and disease. J Am Soc Nephrol 2009;20:1669-1676.
45. Doyonnas R, Kershaw DB, Duhme C et alAnuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 2001;194:13-27.
46. Alexander WS, Viney EM, Zhang JG et alThrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene.Proc NatAcad Sci USA 2006;103:16442-16447.